报价延迟最少15分钟:2025/11/21 15:54 EST
盘后时段
|
||||
|
-- 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
145.3
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.11/0.67
|
|
企业价值
3.99B
|
| 资产负债 |
|
每股账面净值
10.11
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
305.45M
|
|
每股收益
7.14
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. |
